Research and Markets (http://www.researchandmarkets.com/research/80e30e/delivery_technolog) has announced the addition of John Wiley and Sons Ltd's new report "Delivery Technologies for Biopharmaceuticals: Peptides, Prot...
Preliminary research on cancer treatments using nanotechnology and laser therapy has led to a National Science Foundation (NSF) Faculty Early Career Development (CAREER) award for Marissa Nichole Rylander, Virginia Tech assistant professor jointly appointed in the Department of Mechanical Engineering and Virginia Tech – Wake Forest University School of Biomedical Engineering and Sciences (SBES).
A 3.6M€ project cofunded by the 7th EU Framework Program is developing Photonic Crystal technology for multi-target biodetection of Cerebrovascular Disease
Expertise spanning Photonic Crystals to Proteomics is al...
Controlling the way liquids spread across a surface is important for a wide variety of technologies, including DNA microarrays for medical research, inkjet printers and digital lab-on-a-chip systems.
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis announced today that the Institute for Molecular Medicine Finland (FIMM) will launch a cell microarray screening research program utilizing the Aushon 2470 Arrayer technology.
Scientists at Carnegie Mellon University's Department of Chemistry and Molecular Biosensor and Imaging Center (MBIC) are advancing the state-of-the-art in live cell fluorescent imaging by developing a new class of fluorescent probes that span the spectrum - from violet to the near-infrared.
A team of cardiologists, materials scientists, and bioengineers have created and tested a new type of implantable device for measuring the heart's electrical output that they say is a vast improvement over current devices. The new device represents the first use of flexible silicon technology for a medical application.
Arrhythmic hearts soon may beat in time again, with minimal surgical invasion, thanks to flexible electronics technology developed by a team of University of Illinois researchers, in collaboration with the University of Pennsylvania School of Medicine and Northwestern University. These biocompatible silicon devices could mark the beginning of a new wave of surgical electronics.
Biomedical researchers in Bergen are applying nanotechnology to mimic the body's natural processes, create new blood vessels to supply engineered tissue, and deepen our understanding of cancer.
Effective combinati...
Cornerstone Pharmaceuticals, Inc., the private pharmaceutical company focused on therapies exploiting distinctive cancer cell metabolism announced that it has entered into a Collaboration Agreement with the United States National Cancer Institute ("NCI").
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.